Scholarship 24/02290-0 - Malária, Plasmodium vivax - BV FAPESP
Advanced search
Start date
Betweenand

Naturally acquired anti-RBP2b antibodies, red bllod cell invasion blockade, and protection from Plasmodium vivax Malaria

Grant number: 24/02290-0
Support Opportunities:Scholarships in Brazil - Post-Doctoral
Start date until: April 01, 2024
End date until: March 31, 2026
Field of knowledge:Biological Sciences - Parasitology - Protozoology of Parasites
Principal Investigator:Marcelo Urbano Ferreira
Grantee:Natália Soares Ferreira
Host Institution: Instituto de Ciências Biomédicas (ICB). Universidade de São Paulo (USP). São Paulo , SP, Brazil
Associated research grant:22/11963-3 - Individual variation in malaria risk: causes and consequences in Amazonian populations, AP.TEM

Abstract

Recently, the PvRBP2b protein was identified as a key invasion ligand for the malaria parasite Plasmodium vivax, as it binds to the transferrin-1 receptor (CD71) on the surface of immature red blood cells, known as reticulocytes, targeted by the parasite for invasion. Evidence has emerged that naturally acquired antibodies to PvRBP2b are associated with reduced malaria risk in both high- and low-transmission settings. Moreover, host-cell invasion by P. vivax can be partially inhibited ex vivo by murine monoclonal antibodies (mAbs) raised to recombinant PvRBP2b protein. Here we aim to test whether people exposed to low-level malaria transmission in the Brazilian Amazon develop anti-PvRBP2b antibodies that recognize the same epitopes than invasion-inhibitory murine mAbs, whether specific antibody responses are associated with reduced clinical malaria risk, and whether naturally acquired antibodies inhibit P. vivax invasion of reticulocytes ex vivo. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Please report errors in scientific publications list using this form.